Results

Total Results: 537 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

  1. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wx_w92ukxeDvNShoRQXbhP
    September 06, 2016 - professional judgment and patient preferences. … initiating anti–tumor necrosis factor treatment, patients receiving dialysis, patients preparing for … Occupational Safety and Health Administration. … Washington, DC: Occupational Safety and Health Administration; 2015. Directive CPL 02-02-078. 15. … Occupational Safety and Health Administration, US Department of Labor.
  2. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
    August 20, 2019 - Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. … Patients' resistance to risk information in genetic counseling for BRCA1 /2. … Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators … Impact of panel gene testing for hereditary breast and ovarian cancer on patients. … Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1 /2 mutation carriers
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Hfz3GBNZhq5j4SXUt8R2d5
    September 28, 2021 - ing the risk for preeclampsia and discuss the benefits and harms of low-dose aspirin use with their patients … Implementation Risk factors, based on medical history, may help guide clinicians and their patients in … In October 2020, the US Food and Drug Administration released a safety drug communication warning that … Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients … FDA Drug Safety Communication: FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Cjgb95YGBUaHjfn3MNR9xz
    September 28, 2021 - ing the risk for preeclampsia and discuss the benefits and harms of low-dose aspirin use with their patients … Implementation Risk factors, based on medical history, may help guide clinicians and their patients in … In October 2020, the US Food and Drug Administration released a safety drug communication warning that … Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients … FDA Drug Safety Communication: FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later
  5. JAMA (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ymZSPeLcwZ9rxTC-7zdWbp
    July 11, 2022 - ing the risk for preeclampsia and discuss the benefits and harms of low-dose aspirin use with their patients … Implementation Risk factors, based on medical history, may help guide clinicians and their patients in … In October 2020, the US Food and Drug Administration released a safety drug communication warning that … Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients … FDA Drug Safety Communication: FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later
  6. www.uspreventiveservicestaskforce.org/home/getfilebytoken/WEqCV3NvnZAeLdC_pp6nVK
    October 01, 2018 - Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 … Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis … Efficacy and safety of ombitasvir, paritaprevir, and ritonavir in an open-label study of patients with … Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis … Sofosbuvir and velpatasvir combination improves patient-reported outcomes for patients with HCV infection
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qpv8h6ZMbYLYzakVrNQoj2
    October 11, 2022 - disorders among adolescent primary care patients. … Treatment for Adolescents with Depression Study (TADS): safety results. … Accessed February 15, 2021. https://www.fda.gov/ drugs/postmarket-drug-safety-information- patients-and-providers … Suicidality in pediatric patients treated with antidepressant drugs. … Accessed August 16, 2022. https:// www.jointcommission.org/resources/patient- safety-topics/suicide-prevention
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/CW23r2jqogvTG2_-kBjRxH
    January 01, 2007 - Loss of dental enamel in a patient taking cholestyramine. … Increased AST and ALT (1% of patients). … All resolved with patient continuing medication. Transient decreased HCT. … Serum folate decreased in all patients. Table 4. … Endurance running performance in relation to cardiovascular risk indicators in adolescents.
  9. www.uspreventiveservicestaskforce.org/home/getfilebytoken/kGvn_HBPEEdfu2rs38VN8_
    March 11, 2025 - questions that the review will address in order to allow the USPSTF to evaluate the effectiveness and safety … food inse- curity, housing instability, transportation needs, utility help needs, and interpersonal safety … Core indicators of nutritional state for difficult-to-sample populations. … (UP3): a community-based intervention aimed to reduce ultra-processed food intake among food pantry clients … A pilot food bank intervention featuring diabetes- appropriate food improved glycemic control among clients
  10. www.uspreventiveservicestaskforce.org/uspstf/recommendation/asymptomatic-coronary-artery-disease-screening-1996
    January 01, 1996 - Periodic ECG screening is often recommended for persons who might endanger public safety were they to … Cardiac events in such individuals are more likely to affect the safety of a large number of persons, … such as pilots and heavy equipment operators, where sudden death or incapacitation would endanger the safety … of others, considerations other than benefit to the individual patient may favor screening. … Impact of the availability of a prior electrocardiogram on the triage of the patient with acute chest
  11. JAMA JATS (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Nvjr8BPsZhy4XGc7-rGjAH
    June 18, 2018 - Clinicians should understand the evidence but individualize decision making to the specific patient or … professional judgment and patient preferences. … Safety of extending screening intervals beyond five years in cervical screening programmes with testing … Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical … Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/njteJ388DLVsY8RLcBTe_A
    February 25, 2020 - planning, including advance directives; safety planning; legal and financial planning); patient health … Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia … The efficacy and safety of donepezil in patients with Alzheimer’s disease: results of a US multicentre … Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled … Efficacy and safety of galantamine in patients with mild to moderate Alzheimer’s disease: multicentre
  13. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/cognitive-impairment-in-older-adults-screening
    February 25, 2020 - planning, including advance directives; safety planning; legal and financial planning); patient health … Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia … The efficacy and safety of donepezil in patients with Alzheimer’s disease: results of a US multicentre … Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled … Efficacy and safety of galantamine in patients with mild to moderate Alzheimer’s disease: multicentre
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/99YKN27_cW9CRosq9RUMnv
    March 11, 2025 - Viewpoint and Editorial Multimedia Related articles and JAMA Patient Page Supplemental content CME … Clinicians should understand the evidence but individualize decision-making to the specific patient or … food insecurity, housing instability, transporta- tion problems, utility help needs, and interpersonal safety … For example, a clinician may identify a patient with food insecurity, but if the patient or clinician … Development of indicators to assess hunger.
  15. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nonpregnant-adolescents-and-adults1/human-immunodeficiency-virus-hiv-infection-screening
    June 11, 2019 - Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine … in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. … Real-world assessment of renal and bone safety among patients with HIV infection exposed to tenofovir … Comparative safety and neuropsychiatric adverse events associated with efavirenz use in first-line antiretroviral … the key questions that the  review will address to allow the USPSTF to evaluate the effectiveness and safety
  16. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/primary-open-angle-glaucoma-screening
    May 24, 2022 - Data Abstraction and Quality Rating One investigator abstracted details about the study design, patient … Are patient self-reported outcome measures sensitive enough to be used as end points in clinical trials … The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients … Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with … Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor
  17. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
    April 09, 2001 - The safety experience for bile-acid binding resins and niacin, however, is based on a longer period of … Analytical quality of near-patient blood cholesterol and glucose determinations. … Int J Risk Safety Med 1990;1:29–44. 30. Havas S, Reisman J, Hsu L, Koumjian L. … Safety of treatment, changes in risk factors, and incidence of coronary heart disease. … Efficacy and safety of pravastatin in African Americans with primary hypercholesterolemia.
  18. www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
    January 01, 2001 - The safety experience for bile-acid binding resins and niacin, however, is based on a longer period of … Analytical quality of near-patient blood cholesterol and glucose determinations. … Int J Risk Safety Med 1990;1:29–44. 30. Havas S, Reisman J, Hsu L, Koumjian L. … Safety of treatment, changes in risk factors, and incidence of coronary heart disease. … Efficacy and safety of pravastatin in African Americans with primary hypercholesterolemia.
  19. www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
    November 01, 2014 - Clinicians should understand the evidence but individualize decision making to the specific patient or … CLINICAL CONSIDERATIONS Patient Population Under Consideration This recommendation applies to adults … Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy … Accessed at www .aafp.org/patient-care/clinical-recommendations/cps.html on 10 June 2014. … professional judgment and patient preferences.
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/q_zxLD9JZFGoSPCrEHNk2g
    June 11, 2019 - Editorial Author Audio Interview Related articles and JAMA Patient Page Supplemental content Related … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine … Real-world assessment of renal and bone safety among patients with HIV infection exposed to tenofovir … Comparative safety and neuropsychiatric adverse events associated with efavirenz use in first-line antiretroviral

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: